Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferiprone versus deferasirox in paediatric transfusion-dependent haemoglobinopathies
2012-000353-31Phase 3Completed
- Sponsor
- Consorzio per Valutazioni Biologiche e Farmacologiche
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in transfusional hemosiderosis and hemoglobinopathies comparing Deferiprone with Deferasirox (2 arms). Primary endpoint: Successful chelation by serum ferritin and cardiac MRI T2*. Started Oct 2012; status: completed.
02
Drugs
deferipronedeferasirox
03
Conditions
transfusional hemosiderosishemoglobinopathies
Beyond the preview
Go deeper on 2012-000353-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000353-31.